This JAMA Insights Clinical Update reviews current approaches to screening for and managing opioid use disorder, summarizing available screening instruments, diagnostic criteria, and appropriate use of medication-assisted treatment (MAT), including methadone, buprenorphine, and naltrexone.
No takes yet. Share an insight, caveat, or question.
Sarah E. Wakeman (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: